Safety Needles Segment has the Largest Share of Type in the Europe Hypodermic Needles Market during 2021–2028

According to our latest study on “Europe Hypodermic Needles Market Forecast to 2028 – COVID-19 Impact and Analysis – by Type, Application, End User, and Usage,” the market is projected to reach US$ 1,502.9 million by 2028 from US$ 985.8 million in 2021; it is expected to grow at a CAGR of 6.2% from 2021 to 2028. The report highlights trends prevailing in the market, and the drivers and restraints pertaining to the market growth. The growth of this market is estimated to grow owing to key driving factors such as the increasing prevalence of chronic diseases, and surge in demand for vaccines. However, availability of alternatives is hampering the growth of the market to a certain extent.

The COVID-19 Pandemic has necessitated rapid vaccine development for the control of the disease. Most vaccinations, including those currently approved for COVID-19, are administered intramuscularly and subcutaneously using hypodermic needles. Similarly, In March 2021, Catalent Expanded its Partnership with Johnson & Johnson to Significantly Increase Capacity for Sterile Manufacturing and Packaging of COVID-19 Vaccine in Italy. Catalent announced Catalent Biologics would significantly increase the manufacturing capacity for large-scale commercial supply of Janssen’s COVID-19 vaccine at Catalent’s manufacturing facility in Anagni, Italy. Thus, the Europe hypodermic needles market is positively impacted due to COVID-19.

Based on type, the Europe hypodermic needles market is bifurcated into safety needles and non-safety needles. In 2021, the safety needles segment is estimated to account for the largest market share of the type segment in the Europe hypodermic needles market. The growth of these segments is attributed to increasing prevalence of chronic disease, increasing needle stick injuries, and increasing regulation to reduce disease transmission through syringes.

Terumo Corporation, BD, B. Braun Melsungen AG, Catalent Inc., Cardinal Health Inc., Vygon, and Barber of Sheffield are among the leading companies in the Europe hypodermic needles market. The companies are focused on adopting organic growth strategies such as product launches and expansions to sustain their position in the dynamic market.

The market for hypodermic needles market is segmented into type, application, end user, and usage. Based on type, the Europe hypodermic needles market is segmented into safety needles, and non-safety needles. Based on application, the hypodermic needles market is segmented into drug delivery, vaccination, and blood specimen collection. Based on end user, the hypodermic needles market is segmented into diagnostic centers, hospitals and clinics, and home health care. Based on usage, the hypodermic needles market is segmented into disposable, and reusable. Geographically, the hypodermic needles market is segmented into Europe (Germany, UK, France, Spain, Italy, Rest of Europe).

The report segments Europe hypodermic needles market as follows:

The Europe hypodermic needles market is segmented on the basis on ingredient type and sources. Based on ingredient type, the Europe hypodermic needles market is segmented into Probiotics and prebiotics, omega-3 fatty acids, vitamins, carotenoids and antioxidants, plant extracts, minerals, amino acids, proteins and peptides, and others. Based on sources, the market is segmented into plant animal, and microbial.

By Country                                                    

• UK
• Germany
• France
• Italy
• Spain
• Rest of Europe

Contact Us
Phone: +16467917070
Email Id: sales@businessmarketinsights.com